AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,462,000 | -99.8% | 860,000 | 0.0% | 4.73% | +89.3% |
| Q3 2019 | $24,157,400,000 | -33.9% | 860,000 | -10.9% | 2.50% | -26.9% |
| Q2 2019 | $36,534,900,000 | +92604.6% | 965,000 | -4.5% | 3.42% | -21.0% |
| Q1 2019 | $39,410,000 | +114.9% | 1,010,000 | +17.4% | 4.33% | +38.0% |
| Q4 2018 | $18,335,000 | -25.9% | 860,000 | +37.6% | 3.14% | +4.3% |
| Q3 2018 | $24,744,000 | +43.9% | 625,000 | +38.9% | 3.01% | +25.0% |
| Q2 2018 | $17,195,000 | +27.2% | 450,000 | 0.0% | 2.40% | +1.1% |
| Q1 2018 | $13,523,000 | +8.2% | 450,000 | +12.5% | 2.38% | -21.9% |
| Q4 2017 | $12,500,000 | +11.6% | 400,000 | 0.0% | 3.04% | -3.8% |
| Q3 2017 | $11,204,000 | +46.4% | 400,000 | 0.0% | 3.16% | +11.8% |
| Q2 2017 | $7,652,000 | +72.7% | 400,000 | +53.8% | 2.83% | +8.3% |
| Q1 2017 | $4,430,000 | – | 260,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |